LIVN Q2 2017 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$321M+0.1% YoY

Gross Profit

$211M65.6% margin

Operating Income

$31M9.7% margin

Net Income

$47M14.8% margin

EPS (Diluted)

$0.98

QoQ Revenue Growth

+12.7%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$9M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$690M

Stockholders' Equity

$1.8B

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$321M	$321M	+0.1%
Gross Profit	$211M	$190M	+10.8%
Operating Income	$31M	$22M	+41.3%
Net Income	$47M	$9M	+430.3%

Revenue Segments

Cardiac Surgery

$159M49%

Neuromodulation

$97M30%

Cardiac Rhythm Management

$66M20%

Geographic Segments

UNITED STATES

$130M36%

Europe

$105M30%

Non-U.S. and Europe

$87M24%

FRANCE

$34M10%